Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06722846 · ClinicalTrials.gov registry record
Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study.
A clinical trial of Health Options and Strategic Care Planning, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT06722846: Recruiting study of Health Options and Strategic Care Planning, sponsored by M.D. Anderson Cancer Center.
NCT06722846 is a study of Health Options and Strategic Care Planning that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06722846, a study of Health Options and Strategic Care Planning, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn more about how the delivery of medical information affects therapy choices for participants with advanced forms of cancer.
Primary Outcome
Progression Free Survival (PFS)
Conditions Studied
Interventions
- BEHAVIORAL Randomized Case Vignette Study
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-11-21 |
| Est. Completion | 2028-08-31 |
What NCT06722846 shows while recruiting
NCT06722846 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Health Options appearing as the primary indexed condition, and to 1 intervention - of which Randomized Case Vignette Study is the first listed.
NCT06722846 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06722846 about?
NCT06722846 is a clinical study titled "Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study.". To learn more about how the delivery of medical information affects therapy choices for participants with advanced forms of cancer.
What is the current status of trial NCT06722846?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2024-11-21. Estimated completion is 2028-08-31.
What conditions does trial NCT06722846 study?
This clinical trial studies the following conditions: Health Options, Strategic Care Planning.
What interventions are being tested in trial NCT06722846?
The interventions under investigation include: Randomized Case Vignette Study (BEHAVIORAL).
Who is sponsoring clinical trial NCT06722846?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06722846 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI